News – Page 363 – Endpoints News

Takeda joins forces with small private biotech for preclinical Alzheimer's research

3 years ago

Chinook pauses PhI kidney disease trial after serious adverse event

3 years ago

Bavarian Nordic gathers patients for PhIII RSV trial; Adaptimmune handed $37M+ as GSK partnership ends

3 years ago

Exclusive: Cell and gene therapy CDMO VintaBio emerges onto the scene with $64M and a new CEO

3 years ago

After setting up poison pill, Quince Therapeutics board gives flat-out rejection to unsolicited buyer

3 years ago

Extended FTC review adds wrinkle to Sanofi's $2.9B Provention Bio buyout

3 years ago

ARCH-backed HI-Bio touts early data from two trials for rare kidney disease

3 years ago

In a bittersweet transition, Doug Williams takes on his next big biotech challenge

3 years ago

Industry leaders warn that abortion pill ruling puts FDA in 'totally uncharted territory'

3 years ago

Gilead advances Covid-born oncology campaign with patient and advocate stories

3 years ago

Amgen's Bob Bradway takes slight salary dip amid higher pay among US execs

3 years ago

Agency expands video gaming practice with new podcast on 'gamechangers' for pharma and healthcare

3 years ago

Judge orders Merck to hand over adverse events database in Gardasil lawsuit

3 years ago

Medicare spending on CLL drugs skyrockets from $254M to $3.7B in 7 years, JAMA study finds

3 years ago

Meissner invests $250M into a new manufacturing site in Georgia

3 years ago

A new cell therapy biotech emerges to find solid tumor-killing immune cells in patients' blood

3 years ago

Sobi renegotiates nirsevimab deals, to pay $81M for US royalties and axe AstraZeneca agreement

3 years ago

Facing Chapter 11, Clovis sells Rubraca rights to Swiss pharma for $70M

3 years ago

Horizon touts PhIV win for Tepezza; FDA sets adcomm dates for Sarepta, Pfizer, Eisai apps

3 years ago

FDA puts a hold on Molecular Templates' PhI trial for cancer drug

3 years ago

Biogen lays off more employees after reducing headcount last year

3 years ago

Merck and Eisai's Keytruda/Lenvima combo fails PhIII trials for melanoma, colorectal cancer

3 years ago

Texas court ruling on abortion pill opens FDA and its approval decisions to wider political attacks

3 years ago

Digital therapeutics maker Pear files for bankruptcy, lays off 170 staffers — including CEO

3 years ago

First page Previous page 360 361 362363364 365 366 Next page Last page